Safety aspects of treatment with lacidipine—a slow-onset, long-acting calcium antagonist

LH Lindholm, P Tcherdakoff, A Zanchetti - Blood pressure, 1996 - Taylor & Francis
… Whether or not calcium antagonists are as good … calcium antagonists [7-131. This will be
discussed further in this paper which focuses on lacidipine, a vasoselective calcium antagonist

The pharmacological properties of lipophilic calcium antagonists

PA VAN ZWIETEN - Blood pressure, 1998 - Taylor & Francis
slow onset and long duration of action, fewer side-effects such as reflex tachycardia and
headache, owing to the slow onset … -type calcium channels. This phenomenon explains both the …

Calcium antagonists

E Grossman, FH Messerli - Progress in Cardiovascular Diseases, 2004 - Elsevier
… their sites and modes of action on the slow calcium channel, and their effects on various …
calcium antagonists may be put into several pharmacokinetic categories according to their onset

[PDF][PDF] Slowly acting calcium antagonists and their merits

PA Van Zwieten, L Hansson, M Epstein - Blood pressure, 1997 - Taylor & Francis
… , that due attention is paid to the slow onset of action of the newer compounds and its
advantages. It would be more appropriate to characterize them as slow-acting than as long-acting …

Role of a third generation calcium antagonist in the management of hypertension

M Epstein - Drugs, 1999 - Springer
… the concept that calcium antagonists are heterogeneous and … calcium antagonist that is
the prototype of the lipophilic dihydropyridines. Of great importance, lacidipine has a slow onset

The mechanism of action of calcium antagonists relative to their clinical applications.

BN Singh - British journal of clinical pharmacology, 1986 - Wiley Online Library
… However, in the case of hypertensive emergencies, the strikingly rapid onset of action and
the potent vasodilator properties of the dihydropyridines are clearly different from the activity of …

Differential time course of the vasodilator action of various calcium antagonists

R Van der Lee, KL Kam, M Pfaffendorf… - Fundamental & …, 1998 - Wiley Online Library
… Moreover, the combination of a slow onset of action and long duration of action will result
in … In summary, vasoselective CA (DHP) which display a slow onset of action in vitro do not …

The calcium antagonist controversy: the emerging importance of drug formulation as a determinant of risk

M Epstein - The American journal of cardiology, 1997 - Elsevier
… the calcium antagonists together as if they represent a uniform type of agent is erroneous.
The fact that calcium antagonists … the slower onset and longer duration of action of the calcium

Calcium antagonists

WH Frishman, A Cheng-Lai, J Chen - Current Cardiovascular Drugs, 1995 - Springer
Onset of action: rap d Time to peak plasma concentration: SI h Bloavallabltlty: 13%. Increased
In padents with hepatic Impairment. Effect of food: administration of nlmodlplne following a …

Calcium-antagonist drugs

DR Abernethy, JB Schwartz - New England journal of medicine, 1999 - Mass Medical Soc
Drugs classified as calcium antagonists or calcium-channel … calcium antagonists are chemically
diverse, they share the common property of blocking the transmembrane flow of calcium